WASHINGTON, Aug. 27 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV.
The rule was published in the Federal Register on Aug. 27 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.
Summary: On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration (DEA) with a scheduling recommendation to place cipepofol, chemically known as 2-[(1 R)-1-cyclopropylethyl]-6-isopropylphenol, in schedule IV of the Controll...